Medpace Holdings (MEDP)
NASDAQ:MEDP
Want to see MEDP full AI Analyst Report?
Total Valuation
Medpace Holdings has a market cap or net worth of $11.81B. The enterprise value is $11.30B.
Market Cap$11.81B
Enterprise Value$11.30B
Share Statistics
Medpace Holdings has 28,559,689 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,559,689
Owned by Insiders19.42%
Owned by Institutions7.26%
Financial Efficiency
Medpace Holdings’s return on equity (ROE) is 0.98 and return on invested capital (ROIC) is 67.94%.
Return on Equity (ROE)0.98
Return on Assets (ROA)0.23
Return on Invested Capital (ROIC)67.94%
Return on Capital Employed (ROCE)0.85
Revenue Per Employee428.85K
Profits Per Employee76.46K
Employee Count5,900
Asset Turnover1.28
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medpace Holdings is 27.6. Medpace Holdings’s PEG ratio is 1.82.
PE Ratio27.6
PS Ratio6.40
PB Ratio35.29
Price to Fair Value35.29
Price to FCF23.76
Price to Operating Cash Flow15.92
PEG Ratio1.82
Income Statement
In the last 12 months, Medpace Holdings had revenue of 2.53B and earned 451.12M in profits. Earnings per share was 15.64.
Revenue2.53B
Gross Profit760.62M
Operating Income534.93M
Pretax Income542.38M
Net Income451.12M
EBITDA570.50M
Earnings Per Share (EPS)15.64
Cash Flow
In the last 12 months, operating cash flow was 739.17M and capital expenditures -1.36M, giving a free cash flow of 737.82M billion.
Operating Cash Flow739.17M
Free Cash Flow737.82M
Free Cash Flow per Share25.83
Dividends & Yields
Medpace Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.17
52-Week Price Change36.84%
50-Day Moving Average471.52
200-Day Moving Average506.34
Relative Strength Index (RSI)62.65
Average Volume (3m)321.05K
Important Dates
Medpace Holdings upcoming earnings date is Jul 27, 2026, After Close (Confirmed).
Last Earnings DateApr 22, 2026
Next Earnings DateJul 27, 2026
Ex-Dividend Date―
Financial Position
Medpace Holdings as a current ratio of 0.74, with Debt / Equity ratio of 24.42%
Current Ratio0.74
Quick Ratio0.74
Debt to Market Cap<0.01
Net Debt to EBITDA-0.43
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medpace Holdings has paid 91.25M in taxes.
Income Tax91.25M
Effective Tax Rate0.17
Enterprise Valuation
Medpace Holdings EV to EBITDA ratio is 27.97, with an EV/FCF ratio of 23.40.
EV to Sales6.31
EV to EBITDA27.97
EV to Free Cash Flow23.40
EV to Operating Cash Flow22.37
Balance Sheet
Medpace Holdings has $652.68M in cash and marketable securities with $146.09M in debt, giving a net cash position of $506.59M billion.
Cash & Marketable Securities$652.68M
Total Debt$146.09M
Net Cash$506.59M
Net Cash Per Share$17.74
Tangible Book Value Per Share-$8.21
Margins
Gross margin is 29.07%, with operating margin of 21.14%, and net profit margin of 17.83%.
Gross Margin29.07%
Operating Margin21.14%
Pretax Margin21.44%
Net Profit Margin17.83%
EBITDA Margin22.55%
EBIT Margin21.44%
Analyst Forecast
The average price target for Medpace Holdings is $460.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$460.00
Price Target Upside-11.64% Downside
Analyst ConsensusModerate Buy
Analyst Count9
Revenue Growth Forecast24.19%
EPS Growth Forecast20.19%